 
        
        
         
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 描述 | Rhapontin is a natural product isolated and purified from the roots of Rhei Rhizoma. | 
| Concentration | Treated Time | Description | References | |
| HUVECs | 1-100 µg/mL | 24 hours | Evaluation of the effect of Rhapontin on HUVEC viability | Nutrients. 2023 Feb 14;15(4):949 | 
| HEp-2 cells | 10, 20, 40 μg/mL | 24 hours | Evaluate the cytotoxicity of Rhapontin on HEp-2 cells | Vet Res. 2025 Feb 4;56(1):26 | 
| HT1080 cells | 25, 50, 100 µM | 24 hours | To evaluate the effect of RA on MMP-9 activity in HT1080 cells, results showed RA markedly suppressed the PMA-induced increase in MMP-9 activity. | Int J Oncol. 2018 Sep;53(3):1160-1170 | 
| BEAS-2B cells | 0–100 µM | 24 hours | Evaluate the effect of Rhapontin on BEAS-2B cell proliferation, results showed Rhapontin had minimal impact on the proliferation of BEAS-2B cells | Front Mol Biosci. 2024 Jun 11;11:1413214 | 
| A549 cells | 0–100 µM | 24 hours | Evaluate the inhibitory effect of Rhapontin on A549 cell proliferation, results showed Rhapontin had a concentration-dependent proliferation inhibitory effect on A549 cells with an IC50 of 62 μM | Front Mol Biosci. 2024 Jun 11;11:1413214 | 
| HUVECs | 25, 50, 100 µM | 4-12 hours | To evaluate the effect of RA on tube formation in HUVECs, results showed RA significantly inhibited tube-like network formation. | Int J Oncol. 2018 Sep;53(3):1160-1170 | 
| CCRF-CEM | 18.05 µM | 48 hours | Evaluate the cytotoxic and apoptosis-inducing effects of Rhapontin on CCRF-CEM cell line. Results showed Rhapontin significantly reduced cell viability and induced apoptosis. | Molecules. 2019 May 17;24(10):1896 | 
| CEM/C1 | 51.54 µM | 48 hours | Evaluate the cytotoxic and apoptosis-inducing effects of Rhapontin on CEM/C1 cell line. Results showed Rhapontin significantly reduced cell viability and induced apoptosis. | Molecules. 2019 May 17;24(10):1896 | 
| HL60/MX2 | 31.51 µM | 48 hours | Evaluate the cytotoxic and apoptosis-inducing effects of Rhapontin on HL60/MX2 cell line. Results showed Rhapontin significantly reduced cell viability and induced apoptosis. | Molecules. 2019 May 17;24(10):1896 | 
| HL60/MX1 | 28.38 µM | 48 hours | Evaluate the cytotoxic and apoptosis-inducing effects of Rhapontin on HL60/MX1 cell line. Results showed Rhapontin significantly reduced cell viability and induced apoptosis. | Molecules. 2019 May 17;24(10):1896 | 
| HL60 | 41.75 µM | 48 hours | Evaluate the cytotoxic and apoptosis-inducing effects of Rhapontin on HL60 cell line. Results showed Rhapontin significantly reduced cell viability and induced apoptosis. | Molecules. 2019 May 17;24(10):1896 | 
| MDA-MB231 cells | 25, 50, 100 µM | 48 hours | To evaluate the effect of RA on colony formation in MDA-MB231 cells, results showed RA significantly inhibited anchorage-dependent colony formation. | Int J Oncol. 2018 Sep;53(3):1160-1170 | 
| Administration | Dosage | Frequency | Description | References | ||
| Galleria mellonella larvae | Streptococcus suis infection model | Injection | 10, 20, 40 μg/mL | Single dose, observed for 72 hours | Evaluate the protective effect of Rhapontin on Galleria mellonella larvae infection | Vet Res. 2025 Feb 4;56(1):26 | 
| Chick embryos | Chick chorioallantoic membrane (CAM) model | Topical application | 100 µg/embryo | Single dose, observed for 3 days | To evaluate the effect of RA on angiogenesis in the CAM model, results showed RA significantly inhibited spontaneous and VEGF-induced angiogenesis. | Int J Oncol. 2018 Sep;53(3):1160-1170 | 
| C57BL/6J mice | MPTP-induced Parkinson's disease model | Gavage | 20 mg/kg/day | Once daily, throughout the experimental period | Rhapontin ameliorated MPTP-induced gastrointestinal dysfunction and motor symptoms in Parkinson's disease mice by activating NRF2. | World J Gastroenterol. 2025 Apr 21;31(15):104875 | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 2.38mL 0.48mL 0.24mL | 11.89mL 2.38mL 1.19mL | 23.79mL 4.76mL 2.38mL | |
| CAS号 | 155-58-8 | 
| 分子式 | C21H24O9 | 
| 分子量 | 420.41 | 
| SMILES Code | O[C@H]1[C@H](OC2=CC(/C=C/C3=CC=C(OC)C(O)=C3)=CC(O)=C2)O[C@H](CO)[C@@H](O)[C@@H]1O | 
| MDL No. | MFCD00010117 | 
| 别名 | Rhaponiticin; Rhaponticin; trans-Rhapontin; NSC 43321; Rhapontigenin glucoside; Ponticin | 
| 运输 | 蓝冰 | 
| InChI Key | GKAJCVFOJGXVIA-DXKBKAGUSA-N | 
| Pubchem ID | 637213 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C | 
| 溶解方案 | DMSO: 250 mg/mL(594.66 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1